Home Study Programs

To help you obtain continuing education credit as conveniently as possible, NJPhA provides an ongoing and expanding collection of coursework that can be completed from home. As indicated below, some programs are available to NJPhA members only.

If you have any questions about the home study programs, please contact the office.

Important credit information

Please note: If you completed the home study when the original issue of the journal was released, you can not obtain credit for completing it again online. Credit issued to an individual by the course UAN number once.  Please carefully review your   education record on CPE Monitor before enrolling in a home study program.

Help Us to Help You

Support NJPhA PAC

Learn How

NJPhA Benefits

Education, news, networking & more

Get the Details

You Have Enough CE Credits

But are they the right ones?

Check Here

Update on Lipid Management: American Association of Clinical Endocrinologists Hyperlipidemia Guidelines 2017

Dhara D. Shah, PharmD; Christine Lam, PharmD, BCPS, CDE, BCACP

**The authors have no financial or other relevant relationships to disclose.

(Members, free. Nonmembers, $15.)
Members must log in to obtain the members fee. Not a member? Join the Association

Audience

  • Pharmacists
  • Pharmacy Technicians

Credit

  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-18-029-H04-P
  • UAN: 0136-0000-18-029-H04-T

Release Date: August 15, 2018  Expiration Date: August 15, 2021
Activity Type: Knowledge-based

Goal

This paper aims to update pharmacists on the newly developed American Association of Clinical Endocrinologists (AACE) guidelines for management of hyperlipidemia to provide a practical guide for endocrinologists to reduce the risks and consequences of dyslipidemia

Click to view the program's objectives.

At the completion of this activity, pharmacists will be able to:

  • Describe the change from the Four Statin Benefit Groups to ASCVD Risk Categories
  • Apply the shift towards treat-to-target LDL-C levels based on recent evidence based medicine
  • Relate the differences in the risk calculator utilized in the updated guidelines compared to previous guidelines to determine the 10-year ASCVD risk
  • Explain the place in therapy for biomarkers and its association with coronary atherosclerosis

At the completion of this activity, technicians will be able to:

  • Name the change from the Four Statin Benefit Groups to ASCVD Risk Categories
  • Identify the shift towards treat-to-target LDL-C levels
  • List the differences in the previous and updated risk calculators for a patient’s 10-year ASCVD risk

New Drug Update: Delafloxacin (BaxdelaTM) for Acute Bacterial Skin & Skin Structure Infections

Aamer Attaar, PharmD Candidate 2018; Marc Sturgill, PharmD 

**The authors have no financial or other relevant relationships to disclose.

(Members, free. Nonmembers, $15.)
Members must log in to obtain the members fee. Not a member? Join the Association

Audience

  • Pharmacists
  • Pharmacy Technicians

Credit

  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-18-021-H04-P
  • UAN: 0136-0000-18-021-H04-T

Release Date: May 25, 2018  Expiration Date: May 25, 2021
Activity Type: Knowledge-based

Goal

This paper aims to update pharmacists on the use of delafloxacin in treating acute bacterial and skin structural infections.

Click to view the program's objectives.

At the completion of this activity, pharmacists will be able to:

  • Recall specific characteristics of delafloxacin including mechanism of action, dosing, spectrum of coverage, adverse effects, and therapeutic use
  • Analyze and interpret clinical trial data for delafloxacin as it relates to clinical relevance and pharmacokinetics

At the completion of this activity, technicians will be able to:

  • Recall dosing, frequency, and duration of delafloxacin administration
  • Recognize specific compounding and storage instructions for delafloxacin

A Clinical Overview of Human Papillomavirus (HPV) Vaccines

Oishi Rahman, PharmD; Brian Tong, PharmD; Kimberly Erin Ng, PharmD, BCPS*

*corresponding author

**The authors have no financial or other relevant relationships to disclose.

(Members, free. Nonmembers, $15.)

Members must login in to obtain the members fee. Not a member? Join the Association.

Audience

  • Pharmacists
  • Pharmacy Technicians

Credit

  • Contact hours:  1.0 (0.1 CEU)
  • UAN: 0136-0000-18-007-H06-P
  • UAN: 0136-0000-18-007-H06-T

Release Date:  February 20, 2018       Expiration Date:  February 20, 2021

Activity Type:  Knowledge-based

Goal 

The purpose of this assessment is to inform healthcare professionals and allied health professionals of current trends in Human Papillomavirus (HPV) vaccines and their uses in patient HPV prevention.

Click to view the program's objectives.

Objectives

At the completion of this activity, pharmacists will be able to:

  • Identify HPV Types and differentiate those which pose a risk factor for cancer.
  • Describe currently available HPV vaccines
  • Describe reccomendatiosn for HPV vaccines
  • List adverse effects associatied with HPV vaccines

At the completion of this activity, pharmacist technicians will be able to:

  • Define HPV
  • List currently avialable HPV vaccines and HPV types covered by vaccines
  • List adverse effects associated with HPV vaccines

A Systematic Review of Current eHealth Technologies That Foster Medication Adherence

Gino Sinigaglio, PharmD; Aakash Gandhi, PharmD; Rima Patel, MS; Grace Earl, PharmD*

*corresponding author **The authors have no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must login in to obtain the members fee. Not a member? Join the Association.

Audience
  • Pharmacists
  • Pharmacy Technicians
Credit
  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-17-034-H04-P
  • UAN: 0136-0000-17-034-H04-T
 
Release Date: December 1, 2017 Expiration Date: December 1, 2020
     
Activity Type: Knowledge-based     Goal: The purpose of this assessment is to inform healthcare professionals and allied health professionals of emerging eHealth technologies that can be integrated into their practice to overcome adherence barriers.
Click to view the program's objectives.

Objectives

At the completion of this activity, pharmacists will be able to:

  • Justify the use of specific eHealth technologies in improving medication adherence based on the evidence
  • Identify the specific kind of adherence support provided by eHealth technology in improving medication adherence
  • Distinguish the types of eHealth tools based on how the technology is used by the patient or pharmacist in improving medication adherence

At the completion of this activity, pharmacist technicians will be able to:

​

  • Describe the extent of medication non-adherence affecting management of chronic diseases
  • Identify the specific type of adherence support provided by eHealth technology in improving medication adherence
  • Compare the specific types of eHealth technology tools based on the type of technology and type of adherence support

Current and Emerging Therapies of Recurrent Clostridium Difficile Infection: A Review of the Literature

Nicole L. Ryba, PharmD, BCPP, BCGP; Jesse B. Sullivan, PharmD, BCPS, BCCCP; Joseph Cavanaugh, PharmD, BCPS, BCCCP; Jessica Hill, PharmD, BCPS, BCACP **The authors have no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must login in to obtain the members fee. Not a member? Join the Association.
Audience
  • Pharmacists
  • Pharmacy Technicians
Credit
  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-18-038-H01-P
  • UAN: 0136-0000-18-038-H01-T
 
Release Date: November 30, 2018 Expiration Date: November 30, 2021
     
Activity Type: Knowledge-based     Goal: The purpose of this assessment is to inform healthcare professionals and allied health professionals of current and emerging therapies for recurrent Clostridium Difficile Infection as chronicled in recent medical research literature.
Click to view the program's objectives.

Objectives

At the completion of this activity, pharmacists will be able to:

  • Define recurrent C. difficile infection (CDI)
  • Describe guideline recommendations for primary CDI
  • Describe guideline recommendations for recurrence of CDI
  • Identify and Evaluate other emerging therapies for recurrent CDI

At the completion of this activity, pharmacist technicians will be able to:

 

  • Identify first line treatment options for Clostridium difficile infection
  • Describe appropriate dose of treatments options
  • Describe appropriate formulation of treatment options

Resources to Optimize Medication Adherence

Sibyl M. Cherian, PharmD; Christine Lam, PharmD, BCPS **The author has no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association.   Audience

  • Pharmacists
  • Pharmacy Technicians
Credit
  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-17-019-H04-P
  • UAN: 0136-0000-17-019-H04-T
  Release Date: September 8, 2017  Expiration Date: September 8, 2020   Activity Type: Knowledge-based Goal The purpose of this lesson is to provide a brief overview of resources to help optimize medication adherence
Click to view the program's objectives.

Objectives

At the completion of this activity, pharmacists will be able to:

  • Identify barriers to medication adherence
  • Describe management systems and accountability system for coupons, vouchers, and patient assistant program
  • Describe different strategies for improving patient education

At the completion of this activity, pharmacist technicians will be able to:

  • ​List common medication adherence barriers
  • Describe coupon options, vouchers, and patient assistance programs
  • Explain patient education strategies

Zika and the Pharmacist

Asha Gupta, PharmD, RPh

**The author has no financial or other relevant relationships to disclose.

(Members, free. Nonmembers, $15.)
Members must log in to obtain the members fee. Not a member? Join the Association

Audience

  • Pharmacists
  • Pharmacy Technicians

Credit

  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-16-035-H04-P
  • UAN: 0136-0000-16-035-H04-T

Release Date: December 02, 2016 Expiration Date: December 02, 2019
Activity Type: Knowledge-based

Goal

This paper aims to highlight key points that healthcare professionals should know about the Zika virus, as it persists to threaten our communities and healthcare settings.

Click to view the program's objectives.

At the completion of this activity, pharmacists will be able to:

  • Describe Zika viral transmission and prevalence
  • Investigate the prevalence of the Zika virus globally, using information from reliable resources
  • Explain to patients any available prevention methods
  • Identify high-risk areas, populations at-risk, and patients who should be tested if there is possible Zika virus exposure
  • Compile additional resources for personal knowledge and patient education

At the completion of this activity, technicians will be able to:

  • Describe Zika viral transmission and prevalence
  • Investigate the prevalence of the Zika virus globally, using information from reliable resources
  • Identify additional resources for more information on Zika virus

Post-Lumbar Puncture Headache: A Mini-Review for Pharmacists

Maria Leibfried, BS, PharmD, BCNSP, CCP, Daniel Sievers, BS, PharmD Candidate, 2016 **The authors have no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association Audience

  • Pharmacists
  • Pharmacy technicians
Credit
  • Contact hours: 0.5 (0.05 CEU)
  • UAN: 0136-0000-16-015-H04-P
  • UAN: 0136-0000-16-015-H04-T
Release Date: June 03, 2016 Expiration Date: June 03, 2019 Activity Type: Knowledge-based Goal The goal of this lesson is to provide basic background on post-lumbar puncture headaches including epidemiology, clinical presentation, pathophysiology, and recommended treatment options.
Click to view the program's objectives.

At the completion of this activity, pharmacists will be able to

  • Define lumbar puncture (LP)
  • List common adverse effects from LP
  • Discuss post-LP headache
  • Describe treatment options for post-LP headache

At the completion of this activity, pharmacy technicians will be able to

  • Define lumbar puncture (LP)
  • List common adverse effects from LP
  • Define post-LP headache
  • List treatment options for post-LP headache

Oral Emergency Contraception - Clinical and Law Overview for the Pharmacist

Maria Leibfried, BS, PharmD, BCNSP, CCP, Alexandra Libman, PharmD **The authors have no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association. Audience
  • Pharmacists
Credit
  • Contact hours: 1.0 (0.1 CEU)
  • UAN: 0136-0000-16-007-H04-P
Release Date: March, 10, 2016 Expiration Date: March 10, 2019 Activity Type: Knowledge-based
Goal The goal of this lesson is to provide information on currently available oral emergency contraceptives (EC). It will also compare the different oral EC options and discuss New Jersey's laws and regulations that affect the utilization of EC.
Click to view the program's objectives.

At the completion of this activity, pharmacists will be able to

  • Define emergency contraception
  • Describe the different types of emergency contraceptives that are available
  • Explain the regulations surrounding the dispensing of emergency contraception

The Role of Probiotic Supplements in the Prevention and Treatment of Atopic Dermatitis

Celia Lu, PharmD, BCACP

(Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association. Audience
  • Pharmacists and pharmacy technicians
Credit
  • Contact hours: 1.0 (0.1 CEU)
  • UAN number: 0136-0000-16-018-H01-P
  • UAN number: 0136-0000-16-018-H01-T
Release Date: September, 14, 2016 Expiration Date: September, 14, 2019 Activity Type: Knowledge-based Goal This program will review current data that is available regarding the use of probiotics in the prevention and treatment of Atopic Dermatitis.
Click to view the program's objectives.

After participating in this activity, the pharmacist shall be able to:

  • Discuss the possible role of genetics in atopic dermatitis
  • Recognize the role of probiocits in the primary prevention of atopic dermatitis
  • State the pathophysiology of atopic dermatitis

After participating in this activity, the pharmacy technician shall be able to:

  • Discuss the definition of a probiotic
  • Discuss the possible roles of probiotics in the management of inflammatory disease
  • State the role of atopic dermatitis in the allergy

A Brief Review of Acetaminophen and N-Acetylcysteine and its Potential Concomitant Administration

Timothy Nguyen, PharmD, BCPS, CCP, FASCP **The author has no financial or other relevant relationships to disclose. (Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association Audience
  • Pharmacists
  • Pharmacy Technicians
Credit
  • Contact hours – 1.0 (0.1 CEU)
  • UAN: 0136-0000-17-001-H04-P; 0136-0000-17-001-H04-T
Release Date: February 1, 2017 Expiration Date: February 1, 2020 Activity Type: Knowledge-based Goal The purpose of this study was to provide a brief overview of acetaminophen (APAP), N-acetylcysteine (NAC) and the effects of concomitant administration of APAP and NAC.
Click to view the program's objectives.

After participating in this activity, the pharmacist shall be able to:

  • Discuss the possible role of genetics in atopic dermatitis
  • Recognize the role of probiocits in the primary prevention of atopic dermatitis
  • State the pathophysiology of atopic dermatitis

After participating in this activity, the pharmacy technician shall be able to:

  • Discuss the definition of a probiotic
  • Discuss the possible roles of probiotics in the management of inflammatory disease
  • State the role of atopic dermatitis in the allergy

The Pharmacist's Role In Wound Care witha Focus on Dressing Selection

Sean LaFlamme, PharmD, CWCA, CGP, BCPS **The author has no financial or business relationships to disclose in reference to this artricle (Members, free. Nonmembers, $15.) Members must log in to obtain the members fee. Not a member? Join the Association Audience
  • Pharmacists
Credit
  • Contact hours: 0.5 (0.05CEU)
  • UAN: 0136-0000-17-017-H04-P
Release Date: 05/24/17 Expiration Date: 05/24/20 Goal The goal of this activity is to highlight the factors to consider when selecting wound care dressing products
Click to view the program's objectives.

At the completion of the activity, the pharmacists will be able to

  • Determine the place in therapy for common wound care dressing products
  • Identify medical conditions that effect wound healing
  • Review different dressing classes
The New Jersey Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Proof of participation will be submitted to mycpemonitor.net within 60 days subject to documented attendance and completion of online evaluation materials.